* Personalis Inc PSNL.OQ reported a quarterly adjusted
loss
of 64 cents per share for the quarter ended September 30,
lower than the same quarter last year, when the company reported
EPS of -48 cents. The mean expectation of six analysts for the
quarter was for a loss of 35 cents per share. Wall Street
expected results to range from -44 cents to -25 cents per share.
* Revenue rose 40.9% to $25.71 million from a year ago;
analysts
expected $21.32 million.
* Personalis Inc's reported EPS for the quarter was a loss
of 64
cents.
* The company reported a quarterly loss of $39.09 million.
* Personalis Inc shares had risen by 4.8% this quarter and
gained 168.6% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had risen by
about 0.5%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"
Wall Street's median 12-month price target for Personalis Inc is
7.25
This summary was machine generated from LSEG data November 7 at
04:05 a.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2024 -0.37 -0.64 Missed
Jun. 30 2024 -0.37 -0.24 Beat
Mar. 31 2024 -0.41 -0.26 Beat
Dec. 31 2023 -0.50 -0.54 Missed